SUMMARY
Purified toxin and its subunits from Clostridium botulinum type B were labeled with 125iodine and binding of them to rat brain synaptosomes was studied. Labeled toxin and heavy chain were shown to bind to synaptosomes and there was no significant difference in the molar quantity of bound toxin and heavy chain at several concentrations of synaptosomes, whereas labeled light chain did not bind to synaptosomes. The binding of labeled heavy chain to synaptosomes was inhibited by unlabeled toxin and heavy chain to a similar degree as that of labeled toxin. The binding of labeled toxin and heavy chain to synaptosomes were inhibited by a monoclonal antibody which is specific for the heavy chain.
INTRODUCTION
Clostridium botulinum neurotoxins have a common molecular structure composed of a heavy chain (M r about 100000) and a light chain (M r about 50000) linked by one or more disulfide
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bond(s) [1] . These toxins inhibit the acetylcholine release from cholinergic nerve endings, causing neuromuscular paralysis [2] . They are thought to express toxic activity through the process of binding to presynaptic membrane, internalization, and blocking of transmitter release [2] . There exists indirect evidence to suggest that the heavy chain of the toxin molecule is responsible for binding the toxin to presynaptic membranes. This includes competition of heavy chain for binding sites on synaptosomes with whole toxin [3] [4] [5] and inhibition of binding of whole toxin to synaptosomes by polyclonal and monoclonal antibodies specific for the heavy chain [6, 7] . However, there has been no report showing binding properties of heavy chain to presynaptic membranes. This paper reports the binding properties of radioiodinated heavy chain of botulinum type B toxin to rat brain synaptosomes.
MATERIALS AND METHODS

Preparation of type B toxin and its subunits
Clostridium botulinum type B strain L~manna was grown in 6 lite,'s of toxin production medium [8] at 37°C for 5 days. Toxin purification was carried out by the method of DasGupta and Sugiyama [8] . Sabunits of type B toxin were pre-pared by elution from SDS-polyacrylamide gels following the procedure of Hager and Burgess [9] . Protein concentration was determined by the method of Bradford [10] with ovalbumin as a standard. Toxicity was determined by the time to death method [11] .
Preparation and characterization of monoclonal antibodies
Toxoid was prepared by dialyzing purified toxin against 0.4% formalin in 50 mM phosphate buffer, pH 6.0, at room temperature for 1 week. BALB/c mice were immunized with toxoid or heavy chain following the procedure of Hayakawa et al. [12] . Spleen cells were fused with myeloma cells (Sp2/0-Agl4) by 45% polyethylene glycol 4000 (Merck). Antibody-secreting hybrldomas were screened by ELISA with alkaline phosphatase conjugated anti-mouse immunoglobulin (Sigma) and then cloned by limiting dilution. Cloned cells were grown in Dulbecco's modified Eagle medium (Gibco) supplemented with 10% fetal bovine serum (Sigma). The culture supernatant was fractionated with ammonium sulfate at 25 to 50% saturation and dialyzed against PBS at 4°C.
Immunodiffusion tests were carried out with goat antisera to mouse immunoglobulins (Sigma) to determine immunoglobulin (sub)classes of monocional antibodies. To determine the subunit of toxin to which each antibody binds, immuneblotting was carried out by the prodecure of Winston et at. [13] . Neutralizing activity of each antibody was determined as described by Kamata ¢t al. [141.
Radioiodination
150/LCi of 1251 (Amersham) was mixed with 20 /~g of toxin or subunit in 100 /~1 of 100 mM phosphate buffer, pH 7.5. The reaction was initiated by adding 100 ~1 of chloramine T solution (80/~g/ml) and was stopped after 40 s at room temperature by adding 20/~1 of Lqyrosine solution (1 mg/ml), Labeled toxin or subunit was separated from the reaction mixture by gel filtration on a Sephadex (3-25 column (1.0 × 10 cm), proequilibrated with 100 mM sodium phosphate buffer, pH 7.5, coutaining 0,1~ bovine serum albumin, and then dialyzed against the same buffer for 1 day at 4°C.
Binding of type B toxin and its subunits to synaptosomes
Synaptosomes from rat brain were prepared by discontinuous sucrose-gradient centrifugation, as described by Whittaker [15] . Labeled toxin (300 ng), heavy chain (200 ng) or light chain (100 ng) was mixed with various amounts of synaptosomes (0-40/Lg protein) in a total volume of 100/~1 of incubation medium (120 mM NaCI, 2.5 mM KCI, 2 mM CaCI2, 4 mM MgCIz, 0.25~ bovine serum albumin, 10 mM phosphate buffer, pH 7.2). After incubation at 37 °C for 30 min, the reaction was stopped by dilution with 900 /~1 of incubation medium and centrifugation (12000xg for 15 rain). 500/~1 of supernatant (a) and the remaining contents (b) of the vessel were measured for yradiation. Nonspecific binding (c) was determined by incubation in the presence of 500-fold excess of unlabeled toxin over the amounts of labeled toxin or subunits. The radioactivity bound (d) was calculated according to the formula d = b -(a + c).
For testing the inhibition by unlabeled toxin and heavy chain, labeled toxin (30 ng) or heavy chain (20 ng) was mixed with various amounts of unlabeled toxin or heavy chain and then synaptosomes (10/~g protein) were added. After incubation at 37 °C for 30 rain, the reaction was stopped by dilution and centrifugation.
For testing the effects by monoclonal antibodies, labeled toxin (30 ng) or heavy chain (20 ng) was preincubated with various amounts of mono¢lonal antibody for 15 rain at 37°C and then synaptosomes (10/~g protein) were added.
RESULTS AND DISCUSSION
When purified type B toxin was reduced with 55/t-mercaptoethanol, nearly all of the toxin was cleaved into a heavy and a light chain (Fig. IA) . The subunits of type B toxin were prepared by elution from preparative SDS-polacrylamid¢ gels instead of conventional QAE-Scphadex chromatography [161 or gel filtration [17] . The subunits were recovered with about 40% efficiency, Four hybridoma coil lines were established and monoclonal antibodies produced by them were (Table 1) . They all recognized the heavy chain of type B toxin. The neutralizing activity of antibody B3 was much higher than those of the others. Specth¢ radioactivlties of the labeled toxin and subunits were 1.08-1.38 Ci/g protein and the toxicity of labeled toxin was about 84% that of unlabeled toxin. When the labeled toxin and subunits were examined by electrophoresis and autoradiography, they showed electrophoretic mobili- i Type B toxin was diluted to 4× l05 LDso/ml with PBS and mixed with equal volume of each antibody preparation (2 mg/ml). After incubation at 37°C for 30 rain, the remaining toxicity was determined. The data express remaining toxicity.
ties identical to those of unlabeled toxin and subunits (Fig. 1B) . Labeled toxin and its subunits were examined for binding properties to synaptosomes. When labeled toxin or subunits were incubated with various amounts of synaptosomes, binding of light chain was not observed. In contrast, the specific binding of toxin and heavy chain was proportional to the amounts of synaptosomes up to 5 pg of synaptosomal protein (Fig. 2) and there was no significant difference in the moles of bound toxin and heavy chain at the tested concentrations of synaptosomes (Table 2 ). In addition, there was no significant difference in the inhibitory effects of unlabeled toxin and heavy chain (Fig. 3) . The concentrations of unlabeled toxin that induced half-inhibition of the binding of labeled toxin and heavy chain were 1.8 nM and 2.0 nM, respectively. 1he half-inhibition concentrations of unlabeled The molecular masses of toxin and heavy chain were assumed to be 142000 and 98000, respectively. o,
• . heavy chain for the binding of labeled toxin and heavy chain were 2.1 nM and 1.8 nM, respectively. All the results indicate that the heavy chain of botufinum type B toxin has a similar binding ability to synaptosomes as the whole toxin. When compared to previous reports utilizing only labeled toxin [3] [4] [5] [6] [7] , the results obtained in this study provide the first direct evidence for the involvement of heavy chain in binding of botulinum neurotoxin to presynaptic membranes, When monoclonal antibodies, specific for the heavy chain, were tested for the effects on binding of toxin and heavy chain to synaptosomes, similar effects were obs£rvcd in both whole toxin and heavy chain. Antibody B3 inhibited the binding of both toxin and heavy chain effectively, and the others showed little inhibitory effects (Fig, 4) .
